SecurityNGS / Natural Gas Services Group, Inc. (63886Q109)
IndustryOil and Gas Field Services, Not Elsewhere Classified
Common Shares Outstanding13,085,607 shares (as of 2018-03-31)
Total Insiders7
Total Directors5
Total Officers3

Stock Insider Trading (from SEC Form 4)

Natural Gas Services Group, Inc. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

NGS / Natural Gas Services Group, Inc. insiders include Taylor Stephen Charles, BRADSHAW DAVID L, and CHISHOLM JOHN, Hazlett James R, Lawrence G Larry, HUGHES WILLIAM F JR CURTIS CHARLES G, .

Insider Roster

Insider Dir Off 10% Shares Owned
HUGHES WILLIAM F JR Director
X 145,967
Lawrence G Larry Chief Financial Officer
X 57,150
Hazlett James R VP -- Technical Services
X 63,034
CHISHOLM JOHN Director
X 10,964
BRADSHAW DAVID L Director
X 19,572
Taylor Stephen Charles Chief Executive Officer, Director
X X 337,801
CURTIS CHARLES G Director
X 80,085

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-06-30 4 HUGHES WILLIAM F JR By Rabbi Trust M I 899 145,967
2018-06-01 4 HUGHES WILLIAM F JR By the William & Cheryl Hughes Trust G I -4,300 145,068
2018-04-06 4 Hazlett James R F D 24.5 -2,735 63,034
2018-04-06 4 Lawrence G Larry F D 24.5 -2,711 57,150
2018-03-31 4 HUGHES WILLIAM F JR By Rabbi Trust M I 898 149,368
2018-03-28 4 CHISHOLM JOHN S D 23.2 -4,511 10,964 254,365
2018-03-27 4 CHISHOLM JOHN S D 24.07 -9,569 15,475 372,483
2018-03-26 4 CHISHOLM JOHN S D 24.13 -4,110 25,044 604,312
2018-03-23 4 CHISHOLM JOHN S D 24.35 -2,750 29,154 709,900
2018-03-23 4 Lawrence G Larry F D 23.9 -617 54,861
2018-03-23 4 Lawrence G Larry By Rabbi Trust M I 5,000 5,000
2018-03-23 4 Hazlett James R F D 23.9 -513 60,769
2018-03-23 4 Hazlett James R By Rabbi Trust M I 5,000 5,000
2018-03-15 4 HUGHES WILLIAM F JR A D 24.55 407 148,470
2018-03-15 4 CURTIS CHARLES G A D 24.55 4,072 80,085
2018-03-15 4 CHISHOLM JOHN A D 24.55 4,072 31,904
2018-03-15 4 Taylor Stephen Charles A D 24.55 56,749 337,801
2018-03-15 4 Lawrence G Larry A D 24.55 16,000 55,478
2018-03-15 4 Hazlett James R A D 24.55 16,000 61,282
2018-03-15 4 BRADSHAW DAVID L A D 24.55 4,072 19,572
2018-03-13 4 BRADSHAW DAVID L S D 27.35 -1,853 15,500 423,925
2018-03-13 4 BRADSHAW DAVID L S D 27.11 -647 17,353 470,440
2018-02-14 4 Taylor Stephen Charles F D 26.3 -1,278 259,913
2018-02-14 4 Taylor Stephen Charles By Rabbi Trust M I 21,139 21,139
2018-01-25 4 Hazlett James R S D 28.9 -102 45,282 1,308,650
2018-01-25 4 Hazlett James R M D 17.51 102 45,384
2018-01-24 4 Hazlett James R S D 28.9 -200 44,430 1,284,027
2018-01-24 4 Hazlett James R M D 17.51 200 44,630
2018-01-23 4 Hazlett James R S D 29 -513 44,430 1,288,470
2018-01-23 4 Hazlett James R S D 28.95 -979 44,943 1,301,100
2018-01-23 4 Hazlett James R M D 17.51 979 45,922
2018-01-22 4 Hazlett James R S D 28.9 -198 44,943 1,298,853
2018-01-22 4 Hazlett James R M D 17.51 198 45,141
2018-01-17 4 Hazlett James R S D 28.96 -2,005 44,943 1,301,549
2018-01-17 4 Hazlett James R S D 29.01 -1,688 46,948 1,361,961
2018-01-17 4 Hazlett James R M D 17.51 2,005 48,636
2018-01-16 4 Hazlett James R S D 29.02 -1,201 46,631 1,353,232
2018-01-16 4 Hazlett James R S D 28.95 -1,239 47,832 1,384,736
2018-01-16 4 Hazlett James R M D 17.51 1,239 49,071
2018-01-12 4 Hazlett James R S D 28.92 -277 47,832 1,383,301
2018-01-12 4 Hazlett James R M D 17.51 277 48,109
2018-01-06 4 Taylor Stephen Charles F D 27.4 -15,897 261,191
2017-12-27 4 CHISHOLM JOHN S D 26.05 -1,400 27,832 725,024
2017-12-27 4 CHISHOLM JOHN A D 20.48 2,500 29,232
2017-12-27 4 CHISHOLM JOHN S D 26.05 -2,500 26,732 696,369
2017-12-27 4 CHISHOLM JOHN A D 19.61 2,500 29,232
2017-12-21 4 CURTIS CHARLES G A D 20.48 2,500 76,013
2017-12-19 4 Taylor Stephen Charles S D 25.17 -16,212 277,088 6,974,305
2017-12-19 4 Taylor Stephen Charles A D 20.06 16,212 293,300
2017-12-19 4 Lawrence G Larry S D 25.23 -6,000 39,478 996,030
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Natural Gas Services Group, Inc. (NGS) CEO Stephen Taylor on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Natural Gas Services Group, Inc. (NYSE:NGS) Q2 2018 Results Conference Call August 9, 2018 11:00 AM ET

Your Daily Pharma Scoop: IsoRay Doubles, OncoCyte Zooms, Celgene Sluggish

2018-07-11 seekingalpha
Note: ISR has a market cap of less than $100mn and trades below $1. These stocks are inherently risky, and we do not invest in such stocks. However, on Monday, on this news, the stock went above $1, which is when we covered it. (53-6)